Antiretroviral drugs, used to prevent HIV transmission from mother to child, are now believed to cause genetic damage in infants. This damage, leading to an increased risk of developing cancer, makes it highly plausible these children may be diagnosed with the disease in mid and late adulthood.Two new studies indicate there are cancer-causing effects of transplacental exposure to AZT, an antiretroviral drug. These effects -- like increased incidence of tumors and tumors with genetic changes -- have been demonstrated in mice and rats and seem to be cause for concern in humans too.
"The cumulative mutagenesis data suggest that infants exposed transplacentally to AZT may be at increased risk for cancer as they age," said one researcher, whose findings are published in Environment and Molecular Mutagenesis.


Daughters born to mothers who were prescribed the anti-miscarriage drug diethylstilbestrol (DES), a synthetic estrogen, during pregnancy are at increased risk of developing breast cancer, according to research done by a nationwide team of researchers. Between the 1940s through to the 1960s millions of pregnant women were given this drug.
Parents who know they are at high-risk for passing on genetic defects that can lead to disease for their child, have been relying on genetic testing to screen embryos for inherited diseases. British scientists announced today they have developed a
Parents want what is best for baby. No parent wants to expose their baby to cancer-causing chemicals. Because you cannot always rely on baby care product makers to offer only the safest and the best products for your baby, the Environmental Working Group offers
Multiple pregnancies for women who carry the inherited mutations in
In a new report on 







